131 results
8-K
THER
Theralink Technologies, Inc.
13 May 20
Entry into a Material Definitive Agreement
5:10pm
of the Company and Avant to consummate the Asset Sale Transaction will be subject to the satisfaction or waiver of a number of closing conditions … to the satisfaction of the closing conditions set forth in the Asset Purchase Agreement. The issuance of the Series D-1 Preferred by the Company to Avant
8-K
EX-4.1
THER
Theralink Technologies, Inc.
19 May 21
Entry into a Material Definitive Agreement
12:00am
securities for the primary purpose of raising capital) (an “Acquisition”) that occurs prior to the satisfaction in full by the Company of all outstanding … transaction and thereupon the Company shall be obligated to pay Holder an amount equal to the remaining Conversion Amount in full satisfaction of its
8-K
EX-16.1
THER
Theralink Technologies, Inc.
28 Jul 10
Entry into a Material Definitive Agreement
12:00am
or practices, financial statement disclosure, or audit scope and procedures, which disagreement(s), if not resolved to the satisfaction of James
8-K
EX-10.3
fh5kuo
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-4.1
47rvaehbiydpvd
5 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
g7hmpowpm 9n7y
8 May 20
Unregistered Sales of Equity Securities
4:54pm
8-K
EX-10.1
1fd19sq93o8hopg 6n1
28 Jun 12
Entry into a Material Definitive Agreement
12:00am
8-K
q3qmbrkrc
28 Jun 12
Entry into a Material Definitive Agreement
12:00am
8-K
59m2kcuju3
8 Jun 21
Changes in Registrant's Certifying Accountant
5:24pm
8-K
EX-10.2
za15n00ff e3
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.1
hcqtfv6e 7jbzh3s
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.1
5aiorfsfa
7 Mar 11
Unregistered Sales of Equity Securities
12:00am
8-K
EX-10.1
kksjc9kuezo 0w
26 Oct 15
Entry into a Material Definitive Agreement
12:00am